Future Science Holdings Inc
Future Science Holdings Inc. does not have significant operations. Previously, the company was engaged in the exploration and development of titanium deposits or reserves in Chile. The company was incorporated in 1998 and is headquartered in Santiago, Chile.
Future Science Holdings Inc (FUTS) - Net Assets
Latest net assets as of December 2022: $-298.50K USD
Based on the latest financial reports, Future Science Holdings Inc (FUTS) has net assets worth $-298.50K USD as of December 2022.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($387.00) and total liabilities ($298.89K). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $-298.50K |
| % of Total Assets | -77132.82% |
| Annual Growth Rate | N/A |
| 5-Year Change | -117.8% |
| 10-Year Change | N/A |
| Growth Volatility | 51.64 |
Future Science Holdings Inc - Net Assets Trend (2003–2022)
This chart illustrates how Future Science Holdings Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Future Science Holdings Inc (2003–2022)
The table below shows the annual net assets of Future Science Holdings Inc from 2003 to 2022.
| Year | Net Assets | Change |
|---|---|---|
| 2022-12-31 | $-298.50K | -13.82% |
| 2021-12-31 | $-262.25K | -19.04% |
| 2020-12-31 | $-220.31K | -115.75% |
| 2015-12-31 | $1.40 Million | -16.59% |
| 2014-12-31 | $1.68 Million | -61.24% |
| 2013-12-31 | $4.33 Million | +10.80% |
| 2012-12-31 | $3.91 Million | -22.15% |
| 2011-12-31 | $5.02 Million | +4.33% |
| 2010-12-31 | $4.81 Million | +597.04% |
| 2009-12-31 | $-967.40K | -143.04% |
| 2008-12-31 | $2.25 Million | -34.11% |
| 2007-12-31 | $3.41 Million | +25.91% |
| 2006-12-31 | $2.71 Million | -29.71% |
| 2005-12-31 | $3.85 Million | +2740.63% |
| 2004-12-31 | $-145.96K | +68.66% |
| 2003-12-31 | $-465.70K | -- |
Equity Component Analysis
This analysis shows how different components contribute to Future Science Holdings Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 6069460100.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2022)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $100.61K | % |
| Other Comprehensive Income | $-100.61K | % |
| Other Components | $61.59 Million | % |
| Total Equity | $-298.50K | 100.00% |
Future Science Holdings Inc Competitors by Market Cap
The table below lists competitors of Future Science Holdings Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
CHONGQING RURAL -H-
MU:C3B
|
$6.82K |
|
Shezan International Ltd
KAR:SHEZ
|
$6.82K |
|
Andros Pharmaceuticals Co.,Ltd
TWO:6917
|
$6.82K |
|
US AUTO PARTS NTWRK - Frankfurt Stock Exchang
F:ZZF
|
$6.85K |
|
GeneOneLifeScience Inc.
KQ:011000
|
$6.81K |
|
BRIGHOTEL
NSE:BRIGHOTEL
|
$6.81K |
|
EnSync Inc
PINK:ESNC
|
$6.81K |
|
Oxford Metrics plc
LSE:OMG
|
$6.80K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Future Science Holdings Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2021 to 2022, total equity changed from -262,253 to -298,504, a change of -36,251.
- Net loss of 36,251 reduced equity.
- Other factors decreased equity by 0.
Equity Change Factors (2021 to 2022)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-36.25K | -12.14% |
| Total Change | $- | % |
Book Value vs Market Value Analysis
This analysis compares Future Science Holdings Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2003-12-31 | $-0.05 | $0.00 | x |
| 2004-12-31 | $-0.01 | $0.00 | x |
| 2005-12-31 | $0.25 | $0.00 | x |
| 2006-12-31 | $0.12 | $0.00 | x |
| 2007-12-31 | $0.17 | $0.00 | x |
| 2008-12-31 | $0.08 | $0.00 | x |
| 2009-12-31 | $-0.03 | $0.00 | x |
| 2010-12-31 | $0.12 | $0.00 | x |
| 2011-12-31 | $0.09 | $0.00 | x |
| 2012-12-31 | $0.06 | $0.00 | x |
| 2013-12-31 | $0.07 | $0.00 | x |
| 2014-12-31 | $0.02 | $0.00 | x |
| 2015-12-31 | $0.02 | $0.00 | x |
| 2019-12-31 | $0.00 | $0.00 | x |
| 2020-12-31 | $0.00 | $0.00 | x |
| 2021-12-31 | $0.00 | $0.00 | x |
| 2022-12-31 | $0.00 | $0.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Future Science Holdings Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 0.00%
- • Asset Turnover: 0.00x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is above the historical average (-100.31%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2003 | 0.00% | 0.00% | 0.00x | 0.00x | $-784.41K |
| 2004 | 0.00% | 0.00% | 0.00x | 0.00x | $-2.16 Million |
| 2005 | -68.57% | 0.00% | 0.00x | 1.09x | $-3.03 Million |
| 2006 | -80.64% | -206.28% | 0.38x | 1.04x | $-2.46 Million |
| 2007 | -114.97% | -660.33% | 0.17x | 1.02x | $-4.26 Million |
| 2008 | -141.29% | 0.00% | 0.00x | 1.02x | $-3.40 Million |
| 2009 | 0.00% | 0.00% | 0.00x | 0.00x | $-5.76 Million |
| 2010 | -46.72% | 0.00% | 0.00x | 1.52x | $-2.73 Million |
| 2011 | -176.51% | -341.47% | 0.49x | 1.06x | $-9.36 Million |
| 2012 | -216.10% | 0.00% | 0.00x | 1.08x | $-8.83 Million |
| 2013 | -103.84% | 0.00% | 0.00x | 1.11x | $-4.93 Million |
| 2014 | -462.10% | 0.00% | 0.00x | 1.19x | $-7.92 Million |
| 2015 | -294.48% | 0.00% | 0.00x | 1.10x | $-4.26 Million |
| 2019 | 0.00% | 0.00% | 0.00x | 0.00x | $-164.53K |
| 2020 | 0.00% | 0.00% | 0.00x | 0.00x | $-16.46K |
| 2021 | 0.00% | 0.00% | 0.00x | 0.00x | $-20.22K |
| 2022 | 0.00% | 0.00% | 0.00x | 0.00x | $-6.40K |
Industry Comparison
This section compares Future Science Holdings Inc's net assets metrics with peer companies in the Shell Companies industry.
Industry Context
- Industry: Shell Companies
- Average net assets among peers: $36,677,338
- Average return on equity (ROE) among peers: -64.57%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Future Science Holdings Inc (FUTS) | $-298.50K | 0.00% | N/A | $6.82K |
| Artius II Acquisition Inc. Class A Ordinary Shares (AACB) | $-60.27K | 0.00% | 0.00x | $198.37 Million |
| Artius II Acquisition Inc. Units (AACBU) | $-60.27K | 0.00% | 0.00x | $205.28 Million |
| Ares Acquisition Corporation II (AACT-UN) | $931.34 Million | 0.00% | 0.08x | $399.77 Million |
| AA Mission Acquisition Corp. (AAM-UN) | $-559.90 Million | 0.00% | 0.00x | $349.76 Million |
| Global Acquisitions Corporation (AASP) | $3.80 Million | -5.26% | 0.34x | $15.42 Million |
| ABV Consulting Inc (ABVN) | $8.75K | -623.31% | 2.50x | $461.96K |
| Atlantic Coastal Acquisition Corp II (ACAB) | $-8.52 Million | 0.00% | 0.00x | $2.44 Million |
| Annabidiol Corp (ACBD) | $-501.57K | 0.00% | 0.00x | $13.62K |
| ACRO Biomedical Co Ltd (ACBM) | $685.87K | -17.12% | 0.46x | $30.04K |
| Huaizhong Health Group Inc (ADAD) | $-19.47K | 0.00% | 0.00x | $3.15K |